August 17, 2016
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2016 (UNAUDITED)
Media
August 15, 2016
WILSON THERAPEUTICS APPOINTS VINCENT METZLER AS VICE PRESIDENT COMMERCIAL PLANNING & LAUNCH STRATEGY
August 09, 2016
BONESUPPORT™ Receives FDA Approval to Initiate IDE Clinical Study
August 09, 2016
Targovax ASA: Result of the subsequent offering
August 01, 2016
ALTIMMUNE RECEIVES BARDA CONTRACT OF UP TO $120.2 MILLION TO FUND CLINICAL DEVELOPMENT OF FIRST-IN-CLASS ANTHRAX VACCINE CANDIDATE NASOSHIELD
July 30, 2016
Q2 2016 General Market Overview
July 28, 2016
Onxeo Reports First-Half 2016 Business Update and Consolidated Financials
July 28, 2016
Cash position and revenue for the 1st semester of 2016
July 27, 2016
Onxeo Signs Exclusive License Agreement with Pint Pharma for the Commercialization of Beleodaq® in PTCL in South America
July 21, 2016
Nexstim Plc announces long-term financing arrangements in the form of a joint deal with Bracknor and Sitra
